Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study

HIV Medicine

Volumn 13, Issue 2, 2012, Pages 118-126

  Thierfelder, C ^a   Weber, R ^a   Elzi, L ^b   Furrer, H ^c   Cavassini, M ^d   Calmy, A ^e   Bernasconi, E ^f   Gutmann, C ^g   Ledergerber, B ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^g Catonal Hospital St Gallen   (Switzerland)

Author keywords

Cohort study; Gender; HIV infection; Immigrants; Loss to follow up; Participation; Sub Saharan Africa

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AFRICA; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CENTRAL AMERICA; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; EUROPE; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SOUTH AND CENTRAL AMERICA; SWITZERLAND;

ADULT; AFRICA SOUTH OF THE SAHARA; ASIA, SOUTHEASTERN; CARIBBEAN REGION; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EMIGRATION AND IMMIGRATION; EUROPE; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HIV-1; HUMANS; LATIN AMERICA; LOST TO FOLLOW-UP; MALE; SWITZERLAND;

EID: 84855344720     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2011.00949.x     Document Type: Article

References (36)

1. International Organisation for Migration. Global Estimates. 2011. Available at (accessed 5 May 2010).
2. Joint United Nations Programme on HIV/AIDS (UNAIDS). Population Mobility and AIDS Technical update. 2011. Available at (accessed 28 April 2010).
3. Swiss Federal Statistics Office (FSO). Ausländerinnen und Ausländer in der Schweiz, 2008. Available at (accessed 10 March 2010).
4. Swiss Federal Office of Public Health. HIV Epidemiology in Switzerland. Available at (accessed 10 June 2010).
5. Staehelin C, Egloff N, Rickenbach M, Kopp C, Furrer H.Migrants from sub-Saharan Africa in the Swiss HIV Cohort Study: a single center study of epidemiologic migration-specific and clinical features. AIDS Patient Care STDS 2004; 18: 665-675.
6. Swiss Federal Office of Public Health. Migration and Public Health, Summary of the Federal Strategy Phase II (2008-2013). Vol 2011, 2008.
7. Staehelin C, Rickenbach M, Low Net al. Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival. AIDS 2003; 17: 2237-2244.
8. Horstmann E, Brown J, Islam F, Buck J, Agins BD.Retaining HIV-infected patients in care: where are we? Where do we go from here? Clin Infect Dis 2010; 50: 752-761.
9. Wolff H, Stalder H, Epiney M, Walder A, Irion O, Morabia A.Health care and illegality: a survey of undocumented pregnant immigrants in Geneva. Soc Sci Med 2005; 60: 2149-2154.
10. Mocroft A, Kirk O, Aldins Pet al. Loss to follow-up in an international, multicentre observational study. HIV Med 2008; 9: 261-269.
11. Lanoy E, Mary-Krause M, Tattevin Pet al. Predictors identified for losses to follow-up among HIV-seropositive patients. J Clin Epidemiol 2006; 59: 829-835.
12. Poole WK, Perritt R, Shah KBet al. A characterisation of patient drop outs in a cohort of HIV positive homosexual/bisexual men and intravenous drug users. J Epidemiol Commun Health 2001; 55: 66-67.
13. Sabin CA, Schwenk A, Johnson MAet al. Late diagnosis in the HAART era: proposed common definitions and associations with mortality. AIDS 2010; 24: 723-727.
14. Schoni-Affolter F, Ledergerber B, Rickenbach Met al. Cohort profile: the Swiss HIV Cohort Study. Int J Epidemiol 2010: 39: 1179-1189.
15. Joint United Nations Programme on HIV/AIDS. AIDS epidemic update UNAIDS 2007. Available at (accessed 1 January 2010).
16. Health Protection Agency. HIV in the United Kingdom: 2010 Report. Available at (accessed 8 May 2010).
17. Caro-Murillo AM, Gutierrez F, Manuel Ramos Jet al. HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006). Enferm Infecc Microbiol Clin 2009; 27: 380-388.
18. Castilla J, Lorenzo JM, Izquierdo Aet al. Characteristics and trends of newly diagnosed HIV-infections, 2000-2004. Gac Sanit 2006; 20: 442-448.
19. Castilla J, Sobrino P, De La Fuente L, Noguer I, Guerra L, Parras F.Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 2002; 16: 1945-1951.
20. Yebra G, Rivas P, Herrero MDet al. Clinical differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007). AIDS Res Hum Retroviruses 2009; 25: 37-44.
21. Althoff KN, Gange SJ, Klein MBet al. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis 2010; 50: 1512-1520.
22. Gagnon AJ, Merry L, Bocking J, Rosenberg E, Oxman-Martinez J.South Asian migrant women and HIV/STIs: knowledge, attitudes and practices and the role of sexual power. Health Place 2010; 16: 10-15.
23. Corbett EL. HIV and tuberculosis: surveillance revisited. Int J Tuberc Lung Dis 2003; 8: 1009-1021.
24. Rhodes T, Platt L, Maximova Set al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction 2006; 101: 252-266.
25. Kew MC. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol (Paris) 2010; 4: 273-277.
26. Health Protection Agency. A Complex Picture. HIV & Other Sexually Transmitted Infections in the United Kingdom: 2006. Available at (accessed 15 February 2010).
27. Rosen S, Fox MP, Gill CJ.Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 2007; 4: e298.
28. Anderson J. Coming and going: some aspects of care for migrants with HIV in the UK. J Infect 2008; 57: 11-15.
29. Ndiaye B, Ould-Kaci K, Salleron Jet al. Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France - January 1997 to December 2006. Antivir Ther 2009; 14: 567-575.
30. Weber R, Huber M, Rickenbach Met al. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIV Med 2009; 10: 407-416.
31. Fakoya I, Reynolds R, Caswell G, Shiripinda I.Barriers to HIV testing for migrant black Africans in Western Europe. HIV Med 2008; 9(Suppl. 2): 23-25.
32. Braitstein P, Boulle A, Nash Det al. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health (Larchmt) 2008; 17: 47-55.
33. Muula AS, Ngulube TJ, Siziya Set al. Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health 2007; 7: 63.
34. Burns FM, Imrie JY, Nazroo J, Johnson AM, Fenton KA.Why the(y) wait? Key informant understandings of factors contributing to late presentation and poor utilization of HIV health and social care services by African migrants in Britain. AIDS Care 2007; 19: 102-108.
35. Del Amo J, Broring G, Hamers FF, Infuso A, Fenton K.Monitoring HIV/AIDS in Europe's migrant communities and ethnic minorities. AIDS 2004; 18: 1867-1873.
36. Dominicé Dao MI, Ferreira JF, Vallier N, Roulin D, Hirschel B, Calmy A.Health perceptions of African HIV-infected patients and their physicians. Patient Educ Couns 2010; 80: 185-190.